Joint EMA/EORTC Workshop
29 February 2024
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are jointly organising a workshop called “How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?”
This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.
Date: Thursday, 29 February 2024
Location: European Medicines Agency, Amsterdam
Next events
38th EORTC-NCI-AACR Symposium
18 November - 20 November
Barcelona, Spain
European Cancer Summit 2026
18 November - 19 November
Brussels, Belgium
EORTC Gynecological Cancer Group Autumn Meeting 2026
19 November - 20 November
Leiden, Netherlands
EORTC Leukemia Autumn Group Meeting 2026
14 December
New Orleans, USA
CDDF Annual Conference 2027
8 February 2027 @ 09:00 - 10 February 2027 @ 17:00
Antwerp, Belgium
